Precigen, Inc
Nasdaq PGEN · Germantown, MD
Works in Hematology · Infectious disease · Metabolic & endocrine · Oncology · Renal & urogenital · Women's health
Precigen, Inc is a clinical trial sponsor based in Germantown, MD, listed as Nasdaq PGEN. It has 5 active clinical trials with 251 planned participants, across 6 therapeutic areas.
Trial track record · since 2021
Financials · Nasdaq PGEN
Pipeline · 5 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Precigen, Inc
Precigen, Inc is lead sponsor of 5 active clinical trials on ClinicalTrials.gov, with 251 planned participants, in Hematology, Infectious disease, Metabolic & endocrine, Oncology and other areas. Since 2021 it has completed 0 trials and stopped 0 early.
Precigen, Inc is based in Germantown, MD and is listed as Nasdaq PGEN. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Precigen, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-04-23.
Approve Suite is not affiliated with Precigen, Inc. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.